1. Home
  2. ALCO vs PRQR Comparison

ALCO vs PRQR Comparison

Compare ALCO & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

SELL

Current Price

$38.27

Market Cap

297.3M

Sector

N/A

ML Signal

SELL

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

SELL

Current Price

$1.47

Market Cap

262.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ALCO
PRQR
Founded
1960
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.3M
262.5M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
ALCO
PRQR
Price
$38.27
$1.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
★ $45.00
$7.78
AVG Volume (30 Days)
18.5K
★ 720.9K
Earning Date
11-23-2026
11-05-2026
Dividend Yield
★ 0.52%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.32
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.25
Revenue Next Year
N/A
N/A
P/E Ratio
$28.98
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.32
$1.33
52 Week High
$45.01
$3.10

Technical Indicators

Market Signals
Indicator
ALCO
PRQR
Relative Strength Index (RSI) 40.56 27.72
Support Level $37.46 $1.37
Resistance Level $42.05 $1.99
Average True Range (ATR) 0.62 0.08
MACD -0.01 -0.01
Stochastic Oscillator 12.57 17.24

Price Performance

Historical Comparison
ALCO
PRQR

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: